vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $64.3M, roughly 1.9× CAMDEN NATIONAL CORP). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs 3.3%, a 30.7% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs 5.6%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
CAC vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $123.8M |
| Net Profit | $21.9M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | — | 4.3% |
| Net Margin | 34.0% | 3.3% |
| Revenue YoY | — | 4.7% |
| Net Profit YoY | — | 1379.4% |
| EPS (diluted) | $1.29 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $123.8M | ||
| Q3 25 | $65.4M | $128.3M | ||
| Q2 25 | $62.3M | $114.8M | ||
| Q1 25 | $60.1M | $113.2M | ||
| Q4 24 | $47.6M | $118.2M | ||
| Q3 24 | $45.0M | $114.6M | ||
| Q2 24 | $42.8M | $110.6M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $4.1M | ||
| Q3 25 | $21.2M | $5.3M | ||
| Q2 25 | $14.1M | $5.3M | ||
| Q1 25 | $7.3M | $4.7M | ||
| Q4 24 | $14.7M | $-321.0K | ||
| Q3 24 | $13.1M | $4.3M | ||
| Q2 24 | $12.0M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 4.3% | ||
| Q3 25 | 40.5% | 7.0% | ||
| Q2 25 | 28.5% | 3.7% | ||
| Q1 25 | 10.3% | 5.4% | ||
| Q4 24 | 38.7% | 3.8% | ||
| Q3 24 | 35.2% | 4.6% | ||
| Q2 24 | 34.7% | 5.1% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | 3.3% | ||
| Q3 25 | 32.4% | 4.2% | ||
| Q2 25 | 22.6% | 4.6% | ||
| Q1 25 | 12.2% | 4.2% | ||
| Q4 24 | 30.8% | -0.3% | ||
| Q3 24 | 29.1% | 3.8% | ||
| Q2 24 | 28.0% | 1.2% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $0.23 | ||
| Q3 25 | $1.25 | $0.30 | ||
| Q2 25 | $0.83 | $0.28 | ||
| Q1 25 | $0.43 | $0.25 | ||
| Q4 24 | $1.00 | $-0.02 | ||
| Q3 24 | $0.90 | $0.23 | ||
| Q2 24 | $0.81 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $93.9M |
| Total DebtLower is stronger | $514.4M | — |
| Stockholders' EquityBook value | $710.0M | $161.6M |
| Total Assets | $7.0B | $261.1M |
| Debt / EquityLower = less leverage | 0.72× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $93.9M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | — | $81.3M | ||
| Q1 25 | — | $86.5M | ||
| Q4 24 | — | $84.7M | ||
| Q3 24 | — | $78.7M | ||
| Q2 24 | — | $68.7M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $161.6M | ||
| Q3 25 | $676.4M | $166.7M | ||
| Q2 25 | $652.1M | $163.7M | ||
| Q1 25 | $640.1M | $167.1M | ||
| Q4 24 | $531.2M | $161.0M | ||
| Q3 24 | $529.9M | $162.6M | ||
| Q2 24 | $508.3M | $156.4M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $261.1M | ||
| Q3 25 | $7.0B | $264.8M | ||
| Q2 25 | $6.9B | $254.9M | ||
| Q1 25 | $7.0B | $252.7M | ||
| Q4 24 | $5.8B | $240.9M | ||
| Q3 24 | $5.7B | $245.3M | ||
| Q2 24 | $5.7B | $235.8M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $9.9M | ||
| Q3 25 | $36.1M | $18.5M | ||
| Q2 25 | $6.0M | $4.3M | ||
| Q1 25 | $1.0M | $2.6M | ||
| Q4 24 | $60.9M | $12.2M | ||
| Q3 24 | $-14.5M | $9.6M | ||
| Q2 24 | $14.5M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $7.6M | ||
| Q3 25 | $35.4M | $16.8M | ||
| Q2 25 | $4.5M | $3.0M | ||
| Q1 25 | $-727.0K | $1.5M | ||
| Q4 24 | $55.4M | $10.0M | ||
| Q3 24 | $-16.2M | $7.9M | ||
| Q2 24 | $13.2M | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | 6.1% | ||
| Q3 25 | 54.1% | 13.1% | ||
| Q2 25 | 7.3% | 2.6% | ||
| Q1 25 | -1.2% | 1.3% | ||
| Q4 24 | 116.4% | 8.5% | ||
| Q3 24 | -36.0% | 6.9% | ||
| Q2 24 | 30.8% | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 1.9% | ||
| Q3 25 | 1.1% | 1.3% | ||
| Q2 25 | 2.4% | 1.2% | ||
| Q1 25 | 2.9% | 1.0% | ||
| Q4 24 | 11.7% | 1.9% | ||
| Q3 24 | 3.8% | 1.5% | ||
| Q2 24 | 3.0% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | 2.41× | ||
| Q3 25 | 1.70× | 3.46× | ||
| Q2 25 | 0.43× | 0.81× | ||
| Q1 25 | 0.14× | 0.55× | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | 2.21× | ||
| Q2 24 | 1.21× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
